Frequently bought together:
Description
NATtrol™ SARS-CoV-2 (recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. NATtrol™ SARS-CoV-2 (recombinant) Stock can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.
Related Products
NATtrol SARS-CoV-2 E/ORF1ab recombinant Stock
Zeptometrix
€622.00
NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 E gene and portions of the ORF1ab...
NATtrol SARS-Related Coronavirus 2 SARS-CoV-2 Negative Control
Zeptometrix
€206.00 - €237.00
NATtrol™ SARS-CoV-2 External Run Controls are formulated with purified, intact viral particles (Positive control) and human A549 cells (Negative control). The virus particles have been...
NATtrol SARS-Related Coronavirus 2 SARS-CoV-2 Stock
Zeptometrix
€882.00
NATtrol™ SARS-CoV-2 Stock* is formulated with purified, intact viral particles. The virus particles have been chemically modified to render them non-infectious and refrigerator stable. Each...
